The Fly reports that stock analysts at Jefferies Financial Group began covering Kerry Group (OTCMKTS: KRYAY) shares on Wednesday and issued a research note to investors regarding the company simultaneously. The corporation recommended that its shareholders maintain their “hold” position on the company’s shares. In addition, KRYAY has compiled responses from a wide range of other research companies. Berenberg Bank indicated in August 4th, in a research note that was issued on August 4th, that they would be increasing their price objective on Kerry Group shares from €124.00 ($126.53) to €128.00 ($130.61), putting the current price at €124.00.
In a research note released on Monday, June 27th, JPMorgan Chase & Co. announced that they were decreasing their price objective on shares of Kerry Group. The previous price target of €150.00 ($153.06) has been reduced to €135.00 ($137.76). Therefore the new price objective is In a research report published on August 2nd, UBS Group advised its customers to “buy” shares of Kerry Group. They also increased their price objective for the company’s stock from €110.00 ($112.24) to €116.00 ($118.37). Both of these figures are about the company’s stock. The company has been assigned a buy rating by seven separate analysts, with only one of those experts suggesting that shareholders keep holding on to their shares. According to information provided by Bloomberg.com, the average recommendation for the company’s stock is a “Moderate Buy,” and the price target agreed upon for the stock is $2,388.17.
KRYAY shares began trading for the first time on Wednesday, and the price at which they began was $99.09. The ratio of debt to equity is 0.56, the ratio of quick ratio to current ratio is 1.13, and the ratio of current ratio to quick ratio is 1.73. In the past year, Kerry Group’s stock price has ranged from $92.32 to $145.74, with a low of $92.32 and a high of $145.74. Through the companies it owns and manages, Kerry Group plc creates, manufactures, and distributes taste and nutrition solutions for the pharmaceutical, food, and beverage industries across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific region. These markets include Africa, Europe, the Americas, and Asia. Taste & Nutrition and Consumer Foods are the two separate divisions into which the corporation may be broken down.